Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew M Skinner

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Emerging Infectious Diseases|January 22, 2020
Unique Clindamycin-Resistant Clostridioides difficile Strain Related to Fluoroquinolone-Resistant Epidemic BI/RT027 StrainAndrew M Skinner, Laurica Petrella, Farida Siddiqui, et al.
Antimicrobial Agents and Chemotherapy|July 2, 2024
Epidemiology of <i>Clostridioides difficile</i> infection at one hospital 10 years after an outbreak of the epidemic <i>C. difficile</i> strain BI/027: changing strain prevalence, antimicrobial susceptibilities, and patient antibiotic exposuresJeffrey T Wieczorkiewicz, Andrew M Skinner, Adam Cheknis, et al.
Antibiotics (Basel, Switzerland)|July 29, 2023
Effect of the COVID-19 Pandemic on Rates and Epidemiology of <i>Clostridioides difficile</i> Infection in One VA HospitalLorinda M Wright, Andrew M Skinner, Adam Cheknis, et al.
Antimicrobial Stewardship & Healthcare Epidemiology : ASHE|March 20, 2025
Three stages of laboratory stewardship in improving appropriate <i>Clostridioides difficile</i> testing in a community-based settingMichael S Wang, Gretchen Zimmerman, Theres Klein, et al.
Antimicrobial Stewardship & Healthcare Epidemiology : ASHE|August 14, 2025
Erratum: Three stages of laboratory stewardship in improving appropriate <i>Clostridioides difficile</i> testing in a community-based setting-CORRIGENDUMMichael S Wang, Gretchen Zimmerman, Theresa Klein, et al.
Journal of Clinical Medicine|January 5, 2021
The Relative Role of Toxins A and B in the Virulence of <i>Clotridioides difficile</i>Andrew M Skinner, S Tyler Phillips, Michelle M Merrigan, et al.
Journal of Clinical Gastroenterology|November 29, 2023
Fecal Microbiota, Live-jslm for the Prevention of Recurrent Clostridioides difficile Infection : Subgroup Analysis of PUNCH CD2 and PUNCH CD3Paul Feuerstadt, Carl V Crawford, Xing Tan, et al.
Open Forum Infectious Diseases|July 15, 2024
Efficacy of Fecal Microbiota, Live-jslm (REBYOTA®), Among Patients Exposed to Non-<i>Clostridioides difficile</i> Infection Antibiotics: Post Hoc Subgroup Analysis of a Phase 2 Open-Label StudyKelly R Reveles, Anne J Gonzales-Luna, Yoav Golan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 4, 2025
Emergence and Spread of Clostridioides difficile Isolates With Reduced Fidaxomicin Susceptibility in an Acute Care HospitalSarah N Redmond, Jennifer L Cadnum, Annette L Jencson, et al.
Antimicrobial Stewardship & Healthcare Epidemiology : ASHE|April 3, 2026
Molecular epidemiology and clinical differentiation between <i>Clostridioides difficile</i> infection and colonization across three chicago medical centersAndrew M Skinner, Do Young Kim, Adam Cheknis, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Emerging Infectious Diseases|January 22, 2020
Unique Clindamycin-Resistant Clostridioides difficile Strain Related to Fluoroquinolone-Resistant Epidemic BI/RT027 StrainAndrew M Skinner, Laurica Petrella, Farida Siddiqui, et al.
Antimicrobial Agents and Chemotherapy|July 2, 2024
Epidemiology of <i>Clostridioides difficile</i> infection at one hospital 10 years after an outbreak of the epidemic <i>C. difficile</i> strain BI/027: changing strain prevalence, antimicrobial susceptibilities, and patient antibiotic exposuresJeffrey T Wieczorkiewicz, Andrew M Skinner, Adam Cheknis, et al.
Antibiotics (Basel, Switzerland)|July 29, 2023
Effect of the COVID-19 Pandemic on Rates and Epidemiology of <i>Clostridioides difficile</i> Infection in One VA HospitalLorinda M Wright, Andrew M Skinner, Adam Cheknis, et al.
Antimicrobial Stewardship & Healthcare Epidemiology : ASHE|March 20, 2025
Three stages of laboratory stewardship in improving appropriate <i>Clostridioides difficile</i> testing in a community-based settingMichael S Wang, Gretchen Zimmerman, Theres Klein, et al.
Antimicrobial Stewardship & Healthcare Epidemiology : ASHE|August 14, 2025
Erratum: Three stages of laboratory stewardship in improving appropriate <i>Clostridioides difficile</i> testing in a community-based setting-CORRIGENDUMMichael S Wang, Gretchen Zimmerman, Theresa Klein, et al.
Journal of Clinical Medicine|January 5, 2021
The Relative Role of Toxins A and B in the Virulence of <i>Clotridioides difficile</i>Andrew M Skinner, S Tyler Phillips, Michelle M Merrigan, et al.
Journal of Clinical Gastroenterology|November 29, 2023
Fecal Microbiota, Live-jslm for the Prevention of Recurrent Clostridioides difficile Infection : Subgroup Analysis of PUNCH CD2 and PUNCH CD3Paul Feuerstadt, Carl V Crawford, Xing Tan, et al.
Open Forum Infectious Diseases|July 15, 2024
Efficacy of Fecal Microbiota, Live-jslm (REBYOTA®), Among Patients Exposed to Non-<i>Clostridioides difficile</i> Infection Antibiotics: Post Hoc Subgroup Analysis of a Phase 2 Open-Label StudyKelly R Reveles, Anne J Gonzales-Luna, Yoav Golan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 4, 2025
Emergence and Spread of Clostridioides difficile Isolates With Reduced Fidaxomicin Susceptibility in an Acute Care HospitalSarah N Redmond, Jennifer L Cadnum, Annette L Jencson, et al.
Antimicrobial Stewardship & Healthcare Epidemiology : ASHE|April 3, 2026
Molecular epidemiology and clinical differentiation between <i>Clostridioides difficile</i> infection and colonization across three chicago medical centersAndrew M Skinner, Do Young Kim, Adam Cheknis, et al.
Pageof 4